https://www.engineeringnews.co.za

Receive our free daily newsletter:

HIV

HIV (human immunodeficiency virus) is a retrovirus that attacks the body's immune system, specifically targeting CD4 cells (T cells), which help the immune system fight off infections. If left untreated, HIV reduces the number of CD4 cells in the body, making the person more likely to get infections or infection-related cancers. The virus is transmitted through contact with certain body fluids from a person who has HIV, most commonly during unprotected sex or through sharing injection drug equipment. HIV can also be transmitted from mother to child during pregnancy, birth or breastfeeding. Over time, HIV can destroy so many CD4 cells that the body cannot fight off infections and disease, leading to acquired immunodeficiency syndrome (AIDS), the most severe phase of HIV infection. Symptoms of HIV vary depending on the stage of infection, with early-stage symptoms including fever, headache and rash, whilst later stages may involve weight loss, chronic diarrhoea and opportunistic infections. Antiretroviral therapy (ART) can control the virus, allowing people with HIV to live long and healthy lives whilst also preventing transmission to others. Sub-Saharan Africa bears the highest burden of HIV globally, with millions of people living with the virus and significant public-health and economic impacts. Prevention strategies include condom use, pre-exposure prophylaxis (PrEP), voluntary medical male circumcision and harm reduction programmes for people who inject drugs. The virus was first identified in the early 1980s and has since become one of the world's most significant public-health challenges, prompting extensive research, treatment programmes and advocacy efforts.

HIV Updates


Health
Secretive deals, aggressive demands are new US foreign aid tactics
22nd May 2026 By: Bloomberg

On a Friday last November, government officials representing Lesotho, a mountainous enclave in eastern South Africa, sat down in the capital Maseru for three hours of negotiations with Trump... 


The Gilead logo displayed on a cellphone
South Africa seeks local production of Gilead's HIV prevention drug
5th March 2026 By: Reuters

South Africa is asking local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, domestically, in a push to bring production to the region where it... 


1

Option 1 (equivalent of R125 a month):

Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format

Option 2 (equivalent of R375 a month):

All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.

Already a subscriber?

Forgotten your password?

MAGAZINE & ONLINE

SUBSCRIBE

RESEARCH CHANNEL AFRICA

SUBSCRIBE

CORPORATE PACKAGES

CLICK FOR A QUOTATION







301

pqt: 0.123s - ct: 2.125s - 146pq - 2rq
Subscribe Now